Hemispherx (HEB) Execs Empty Their Piggy Banks To Buy Some Stock

Hemispherx Biopharma, Inc. (NYSE: HEB) Medical Director David Strayer bought 12,000 shares on 12/07 at $0.5654 per share, bringing his stake to 51,246 shares.

This purchase follows the disclosed purchase of 30,000 shares by CEO Carter yesterday.

It should be noted that the dollar amount of these trades is very low, with today's disclosure about $6K. Excuse me sir, do you need to margin that?

Get Market Moving News Alerts - 2 Week Free Trial http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• On Holding AG (ONON) Insider Trades
• Beeline CEO puts $500,000 into company via convertible note
• Intel CEO to buy $12 million in company stock in recent stock offering